Personas / Equipo Humano

Jordi Antón López

Buscador de publicaciones

Publicaciones

  • Quartier P, Alexeeva E, Tamàs C, Chasnyk V, Wulffraat N, Palmblad K, Wouters C, Brunner H, Marzan K, Schneider R, Horneff G, Martini A, Anton-Lopez J, Wei X, Slade A, Ruperto N, Abrams K and Pediatric Rheumatology International Trials Organization (PRINTO), the Pediatric.

    Tapering Canakinumab Monotherapy in Patients With Systemic Juvenile Idiopathic Arthritis in Clinical Remission: Results From a Phase IIIb/IV Open-Label, Randomized Study

    ARTHRITIS & RHEUMATOLOGY . 73(2): 336-346. Nº de citas: 26

    [doi:10.1002/art.41488]

  • Fernández-Cooke E, Grasa CD, Domínguez-Rodríguez S, Barrios Tascón A, Sánchez-Manubens J, Anton-Lopez J, Mercader B, Villalobos E, Camacho M, Navarro Gómez ML, Oltra Benavent M, Giralt G, Bustillo M, Bello Naranjo AM, Rocandio B, Rodríguez-González M, Núñez Cuadros E, Aracil Santos J, Moreno D and Calvo C.

    Prevalence and Clinical Characteristics of SARS-CoV-2 Confirmed and Negative Kawasaki Disease Patients During the Pandemic in Spain

    Frontiers in pediatrics . 8: 617039-617039. Nº de citas: 8

    [doi:10.3389/fped.2020.617039]

  • García-Salido A, Anton-Lopez J, David Martínez-Pajares J, Garcia GG, Cortés BG and Tagarro A.

    Spanish consensus document on diagnosis, stabilisation and treatment of pediatric multisystem inflammatory syndrome related to SARS-CoV-2 (SIM-PedS).

    anales de pediatria . 94(2): .

    [doi:10.1016/j.anpede.2020.09.005]

  • Brunner HI, Abud-Mendoza C, Viola DO, Calvo Penades I, Levy D, Anton-Lopez J, Calderon JE, Chasnyk VG, Ferrandiz MA, Keltsev V, Paz Gastanaga ME, Shishov M, Boteanu AL, Henrickson M, Bass D, Clark K, Hammer A, Ji BN, Nino A, Roth DA, Struemper H, Wang ML, Martini A, Lovell D, Ruperto N and Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pedia.

    Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trial

    ANNALS OF THE RHEUMATIC DISEASES . 79(10): 1340-1348. Nº de citas: 100

    [doi:10.1136/annrheumdis-2020-217101]

  • Deyà-Martinez A, Gordón Y, Molina-Anguita C, Vlagea A, Piquer-Gibert M, Juan-Otero M, Esteve-Solé A, Anton-Lopez J, Madrid Á, García-García A, Plaza-Martín AM, Armangue-Salvador T and Alsina L.

    Single-cycle rituximab-induced immunologic changes in children Enhanced in neuroimmunologic disease?

    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION . 7(4): 724. Nº de citas: 11

    [doi:10.1212/NXI.0000000000000724]

  • Giancane G, Swart JF, Castagnola E, Groll AH, Horneff G, Huppertz HI, Lovell DJ, Wolfs T, Herlin T, Dolezalova P, Sanner H, Susic G, Sztajnbok F, Maritsi D, Constantin T, Vargova V, Sawhney S, Rygg M, K Oliveira S, Cattalini M, Bovis F, Bagnasco F, Pistorio A, Martini A, Wulffraat N, Ruperto N and Paediatric Rheumatology International Trials Organisation (PRINTO).

    Opportunistic infections in immunosuppressed patients with juvenile idiopathic arthritis: analysis by the Pharmachild Safety Adjudication Committee.

    ARTHRITIS RESEARCH & THERAPY . 22(1): 71-71. Nº de citas: 22

    [doi:10.1186/s13075-020-02167-2]

  • Foeldvari I, Klotsche J, Simonini G, Edelsten C, Angeles-Han ST, Bangsgaard R, de Boer J, Brumm G, Torrent RB, Constantin T, DeLibero C, Diaz J, Gerloni VM, Guedes M, Heiligenhaus A, Kotaniemi K, Leinonen S, Minden K, Miranda V, Miserocchi E, Nielsen S, Niewerth M, Pontikaki I, García de Vicuña-Muñoz C, Zilhao C, Yeh S, Anton-Lopez J and Calzada-Hernández J.

    Proposal for a definition for response to treatment, inactive disease and damage for JIA associated uveitis based on the validation of a uveitis related JIA outcome measures from the Multinational Interdisciplinary Working Group for Uveitis in Childhood (MIWGUC)

    PEDIATRIC RHEUMATOLOGY . 17(1): 66-66. Nº de citas: 30

    [doi:10.1186/s12969-019-0345-2]

  • Gattorno M, Hofer M, Federici S, Vanoni F, Bovis F, Aksentijevich I, Anton-Lopez J, Arostegui-Gorospe JI, Barron K, Ben-Cherit E, Brogan PA, Cantarini L, Ceccherini I, De Benedetti F, Dedeoglu F, Demirkaya E, Frenkel J, Goldbach-Mansky R, Gul A, Hentgen V, Hoffman H, Kallinich T, Kone-Paut I, Kuemmerle-Deschner J, Lachmann HJ, Laxer RM, Livneh A, Obici L, Ozen S, Rowczenio D, Russo R, Shinar Y, Simon A, Toplak N, Touitou I, Uziel Y, van Gijn M, Foell D, Garassino C, Kastner D, Martini A, Sormani MP and Ruperto N.

    Classification criteria for autoinflammatory recurrent fevers.

    ANNALS OF THE RHEUMATIC DISEASES . 78(8): 1025-1032. Nº de citas: 295

    [doi:10.1136/annrheumdis-2019-215048]

  • Zulian F, Culpo R, Sperotto F, Anton-Lopez J, Avcin T, Baildam EM, Boros C, Chaitow J, Constantin T, Kasapcopur O, Knupp Feitosa de Oliveira S, Pilkington CA, Russo R, Toplak N, van Royen A, Saad Magalhães C, Vastert SJ, Wulffraat NM and Foeldvari I.

    Consensus-based recommendations for the management of juvenile localised scleroderma

    ANNALS OF THE RHEUMATIC DISEASES . 78(8): 1019-1024. Nº de citas: 69

    [doi:10.1136/annrheumdis-2018-214697]

  • Mastrangelo G, Foeldvari I, Anton-Lopez J and Simonini G.

    Defining outcome measures in juvenile idiopathic arthritis associated uveitis by a systematic review analysis: do we need a consensus?

    PEDIATRIC RHEUMATOLOGY . 17: 40-40. Nº de citas: 10

    [doi:10.1186/s12969-019-0330-9]